pteridines has been researched along with B16 Melanoma in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "DC-TA-46 was found to inhibit growth of B16 melanoma and MCF-7 mammary carcinoma cells dose dependently (B16: IC50 = 1." | 1.29 | 3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition. ( Drees, M; Eisenbrand, G; Zimmermann, R, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Drees, M | 1 |
| Zimmermann, R | 1 |
| Eisenbrand, G | 1 |
1 other study available for pteridines and B16 Melanoma
| Article | Year |
|---|---|
3',5'-Cyclic nucleotide phosphodiesterase in tumor cells as potential target for tumor growth inhibition.
Topics: 2',3'-Cyclic-Nucleotide Phosphodiesterases; Animals; Anion Exchange Resins; Antineoplastic Agents; B | 1993 |